Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021Business Wire • 11/01/21
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)Business Wire • 10/28/21
Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results PresentationBusiness Wire • 10/28/21
Agilent Announced as My Green Lab's First 'Transformative Level' Sponsor and First Sponsor of the My Green Lab Certification ProgramPRNewsWire • 10/26/21
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaBusiness Wire • 10/21/21
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast CancerBusiness Wire • 10/13/21
Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)Business Wire • 09/28/21
Agilent Announces Thought Leader Award to David R. Liu at the Broad InstituteBusiness Wire • 09/07/21
Has Agilent Technologies (A) Outpaced Other Computer and Technology Stocks This Year?Zacks Investment Research • 09/03/21
Agilent and Visiopharm Expand Collaboration with Worldwide Distribution AgreementBusiness Wire • 09/02/21
Agilent Technologies (A) Boasts Earnings & Price Momentum: Should You Buy?Zacks Investment Research • 09/01/21